Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Esophageal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Study leads
Xiaolin Ge, PHD
Study Chair
The First Affiliated Hospital with Nanjing Medical University